Atara Biotherapeutics (ATRA) Interest Coverage Ratio Growth (1y) (2014 - 2026)
Atara Biotherapeutics (ATRA) Interest Coverage Ratio Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,799.45 Bn | 1,799.39 Bn | - | - |
| 2 | Akari Therapeutics | 994.00 Bn | 994.00 Bn | - | -347.04% |
| 3 | BeOne Medicines | 472.71 Bn | 467.91 Bn | 1.35 Bn | 787.12% |
| 4 | Vertex Pharmaceuticals | 124.82 Bn | 117.58 Bn | 2.59 Bn | 53.59% |
| 5 | Regeneron Pharmaceuticals | 71.80 Bn | 63.05 Bn | 3.31 Bn | -32.04% |
| 6 | Belite Bio | 61.76 Bn | 61.76 Bn | - | -100.00% |
| 7 | Argenx Se | 54.26 Bn | 49.08 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.12 Bn | 35.11 Bn | 959.66 Mn | 1,378.45% |
| 9 | Revolution Medicines | 36.29 Bn | 36.29 Bn | - | 73.00% |
| 10 | Atara Biotherapeutics | 105.19 Mn | 96.83 Mn | 392,000.00 | -143.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -143.30% |
| Dec 31, 2025 | -828.70% |
| Sep 30, 2025 | 96.93% |
| Jun 30, 2025 | 100.91% |
| Mar 31, 2025 | 219.80% |
| Dec 31, 2024 | -151.16% |
| Sep 30, 2024 | 63.14% |
| Jun 30, 2024 | 72.12% |
| Mar 31, 2024 | 86.06% |
| Dec 31, 2023 | 99.26% |
| Sep 30, 2023 | -5,562.65% |
| Jun 30, 2023 | -2,808.79% |
| Mar 31, 2023 | 64.55% |
| Dec 31, 2022 | 95.16% |
| Sep 30, 2022 | 75.94% |
| Jun 30, 2022 | 73.77% |
| Mar 31, 2022 | -1,437.39% |
| Dec 31, 2021 | -46,088.74% |
| Sep 30, 2021 | 80.46% |
| Jun 30, 2021 | 27.94% |